Incremental Cost Effectiveness of Bedaquiline for the Treatment of Rifampicin-Resistant Tuberculosis in South Africa: Model-Based Analysis
General Info
Coverage type
Country
Time period covered
January, 2011 - December, 2016
Data type
Scientific literature
Citation
Journal
Appl Health Econ Health Policy
Pages
43-54
Publication year
2018
Suggested citation
Schnippel K, Firnhaber C, Conradie F, Ndjeka N, Sinanovic E. Incremental Cost Effectiveness of Bedaquiline for the Treatment of Rifampicin-Resistant Tuberculosis in South Africa: Model-Based Analysis. Appl Health Econ Health Policy. 2018; 16(1): 43-54.